Healthcare & Life Sciences
Inograft Biotherapeutics
United States
seed
seed
Stage
1
Investors
About
Inograft Biotherapeutics develops non-genotoxic conditioning regimens to improve the outcomes of hematopoietic stem cell transplantation.
Explore Inograft Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.